(Q36697477)

15 August 2017

1 reference

title

Use of antiepileptic drugs for nonepileptic conditions: psychiatric disorders and chronic pain (English)

1 reference

15 August 2017

0 references

1

Alan B Ettinger

1 reference

15 August 2017

Charles E Argoff

2

1 reference

15 August 2017

publication date

1 January 2007

1 reference

15 August 2017

1 reference

15 August 2017

volume

4

1 reference

15 August 2017

issue

1

1 reference

15 August 2017

page(s)

75-83

1 reference

Anticonvulsants in the treatment of bipolar mania

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Depression, IV: STAR*D treatment trial for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Assessing clinical and functional outcomes in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

PET imaging of 5-HT1A receptor binding in patients with temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Brain Serotonin1A Receptor Binding Measured by Positron Emission Tomography With [11C]WAY-100635

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Anticonvulsant doses of carbamazepine increase hippocampal extracellular serotonin in genetically epilepsy-prone rats: dose response relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Lamotrigine inhibits monoamine uptake in vitro and modulates 5-hydroxytryptamine uptake in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

The effect of valproic acid on 5-hydroxytryptamine and 5-hydroxyindoleacetic acid concentration in hippocampal dialysates in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Disregulation of hypothalamic-pituitary-adrenal axis in the mentally retarded

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Benzodiazepine withdrawal delirium with catatonic features. Occurrence in patients with partial seizure disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Double-blind 18-month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Divalproex therapy in medication-naive and mood-stabilizer-naive bipolar II depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Placebo-controlled study of divalproex sodium for agitation in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Sodium valproate in the treatment of aggressive behavior in patients with dementia--a randomized placebo controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Prophylactic effect of phenytoin in bipolar disorder: a controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

A comparison of anticonvulsants in the treatment of impulsive aggression

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Antiepileptic drugs in mood-disordered patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Tiagabine in treatment refractory bipolar disorder: a clinical case series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Treatment of social phobia with gabapentin: a placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

A randomized, open-label, controlled trial of gabapentin and phenobarbital in the treatment of alcohol withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Gabapentin for the treatment of behavioural alterations in dementia: preliminary 15-month investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Efficacy of pregabalin in the treatment of generalized anxiety disorder: double-blind, placebo-controlled comparison of BID versus TID dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Psychiatric adverse events during levetiracetam therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Levetiracetam psychosis in children with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Levetiracetam in bipolar spectrum disorders: first evidence of efficacy in an open, add- on study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Oxcarbazepine as add-on treatment in patients with bipolar manic, mixed or depressive episode

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Acute antimanic efficacy and safety of oxcarbazepine in an open trial with an on-off-on design

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Topiramate and divalproex in combination with risperidone for acute mania: a randomized open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Open-label adjunctive topiramate in the treatment of bipolar disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

A past psychiatric history may be a risk factor for topiramate-related psychiatric and cognitive adverse events

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Tolerability of topiramate in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Topiramate-induced psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Acute psychotic disorders induced by topiramate: report of two cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Behavioural effects of the newer antiepileptic drugs: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Worsening of psychosis or topiramate-induced adverse event?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Treatment of aggression with topiramate in male borderline patients: a double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Effects of Topiramate on Aggressive, Self-Injurious, and Disruptive/Destructive Behaviors in the Intellectually Disabled: An Open-Label Retrospective Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Prospective open-label study of add-on and monotherapy topiramate in civilians with chronic nonhallucinatory posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Use of anticonvulsants for treatment of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13-week, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Gabapentin for the Treatment of Postherpetic Neuralgia: A Randomized Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Efficacy of gabapentin in migraine prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

A randomized study of the effects of single-dose gabapentin versus placebo on postoperative pain and morphine consumption after mastectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Carbamazepine in the treatment of neuralgia. Use of side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

The analgesic effect of tocainide in trigeminal neuralgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Pimozide therapy for trigeminal neuralgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Topiramate in migraine prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Prophylaxis of migraine, transformed migraine, and cluster headache with topiramate

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

The rationale and use of topiramate for treating neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Topiramate in chronic lumbar radicular pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Clinical studies of valproate for migraine prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Phenytoin in the treatment of diabetic symmetrical polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Lamotrigine for central poststroke pain: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Lamotrigine for HIV-associated painful sensory neuropathies: a placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Pharmacotherapy of trigeminal neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Lamotrigine in spinal cord injury pain: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

200 mg daily of lamotrigine has no analgesic effect in neuropathic pain: a randomised, double-blind, placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Oxcarbazepine: a new drug in the management of intractable trigeminal neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

Lamotrigine (Lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.10.003

An open-label study of levetiracetam for the treatment of social anxiety disorder

21 January 2018

1 reference

12 December 2020

Topiramate treatment of aggression in female borderline personality disorder patients: a double-blind, placebo-controlled study.

1 reference

12 December 2020

Topiramate for acute affective episodes in bipolar disorder

1 reference

12 December 2020

Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine (Tegretol�): Double blind crossover trial

1 reference

12 December 2020

A four year double-blind study of tegretol in facial pain

1 reference

12 December 2020

Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial.

1 reference

12 December 2020

Levetiracetam in the treatment of acute mania: an open add-on study with an on-off-on design

1 reference

12 December 2020

Tiagabine appears not to be efficacious in the treatment of acute mania

1 reference

12 December 2020

Intravenous infusion of phenytoin relieves neuropathic pain: a randomized, double-blinded, placebo-controlled, crossover study

1 reference

12 December 2020

Antiepileptic drugs: indications other than epilepsy.

1 reference

12 December 2020

Controlled double-blind trial of phenytoin vs. fluoxetine in major depressive disorder.

1 reference

12 December 2020

A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes.

1 reference

12 December 2020

Panic disorder: treatment with valproate

1 reference

12 December 2020

Divalproex in the Treatment of Impulsive Aggression: Efficacy in Cluster B Personality Disorders

1 reference

12 December 2020

Double blind study of the effects of diphenylhydantoin sodium on diabetic neuropathy

1 reference

12 December 2020

Central post-stroke pain--a controlled trial of amitriptyline and carbamazepine

1 reference

12 December 2020

A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.

1 reference

12 December 2020

Gabapentin: long-term antianxiety and hypnotic effects in psychiatric patients with comorbid anxiety-related disorders.

1 reference

12 December 2020

Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes.

1 reference

12 December 2020

Differential response to lithium and carbamazepine in the prophylaxis of bipolar disorder

1 reference

12 December 2020

Regional induction of fos immunoreactivity in the brain by anticonvulsant stimulation of the vagus nerve

1 reference

12 December 2020

Carbamazepine in manic-depressive illness: a new treatment

1 reference

12 December 2020

Two cases of nonconvulsive status epilepticus in association with tiagabine therapy

1 reference

12 December 2020

Tizanidine in the management of trigeminal neuralgia

1 reference

12 December 2020

Topiramate in painful diabetic polyneuropathy: findings from three double-blind placebo-controlled trials

1 reference

12 December 2020

A preliminary open-label study of zonisamide treatment for bipolar depression in 10 patients

1 reference

12 December 2020

A 52-week, open-label continuation study of lamotrigine in the treatment of bipolar depression.

1 reference

12 December 2020

Efficacy of gabapentin in treating chronic phantom limb and residual limb pain

1 reference

12 December 2020

Worsening of psychosis after replacement of adjunctive valproate with topiramate in a schizophrenia patient.

1 reference

12 December 2020

A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder.

1 reference

12 December 2020

A 6-month, multicenter, open-label evaluation of beaded, extended-release carbamazepine capsule monotherapy in bipolar disorder patients with manic or mixed episodes

1 reference

12 December 2020

Accelerated weight loss after treating refractory depression with fluoxetine plus topiramate: possible mechanisms of action?

1 reference

12 December 2020

Topiramate as add-on treatment for patients with bipolar mania

1 reference

12 December 2020

Evidence that carbamazepine and antiepilepsirine may produce a component of their anticonvulsant effects by activating serotonergic neurons in genetically epilepsy-prone rats

1 reference

12 December 2020

Phenytoin as an antimanic anticonvulsant: a controlled study

1 reference

12 December 2020

Open-label adjunctive zonisamide in the treatment of bipolar disorders: a prospective trial.

1 reference

12 December 2020

Tiagabine for the treatment of generalized anxiety disorder: a randomized, open-label, clinical trial with paroxetine as a positive control.

1 reference

12 December 2020

A case report of reduction in alcohol craving and protection against alcohol withdrawal by gabapentin

1 reference

12 December 2020

Topiramate in Treatment of Patients With Chronic Low Back Pain

1 reference

12 December 2020

Acute psychotic disorders induced by topiramate: report of two cases

1 reference

12 December 2020

Efficacy of divalproex sodium in patients with panic disorder and mood instability who have not responded to conventional therapy.

1 reference

12 December 2020

Prophylactic efficacy of lithium versus carbamazepine in treatment-naive bipolar patients.

1 reference

12 December 2020

10.1016/J.NURT.2006.10.003

Identifiers

DOI

1 reference

Dimensions Publication ID

15 August 2017

1000157956

0 references

1 reference